Header Logo

Connection

Elinor Karlsson to Protein Tyrosine Phosphatase, Non-Receptor Type 2

This is a "connection" page, showing publications Elinor Karlsson has written about Protein Tyrosine Phosphatase, Non-Receptor Type 2.
  1. Karlsson E, Veenstra C, G?rsj? J, Nordenskj?ld B, Fornander T, St?l O. PTPN2 deficiency along with activation of nuclear Akt predict endocrine resistance in breast cancer. J Cancer Res Clin Oncol. 2019 Mar; 145(3):599-607.
    View in: PubMed
    Score: 0.620
  2. Veenstra C, Karlsson E, Mirwani SM, Nordenskj?ld B, Fornander T, P?rez-Tenorio G, St?l O. The effects of PTPN2 loss on cell signalling and clinical outcome in relation to breast cancer subtype. J Cancer Res Clin Oncol. 2019 Jul; 145(7):1845-1856.
    View in: PubMed
    Score: 0.159
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.